Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Dalteparina de sodio")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 96

  • Page / 4
Export

Selection :

  • and

Ensuring safety of biosimilar low-molecular-weight heparins: a consensus statement of the International Union of AngiologyHARENBERG, J; KALODIKI, E; WALENGA, J. M et al.International angiology. 2012, Vol 31, Num 2, pp 101-104, issn 0392-9590, 4 p.Article

Does low molecular weight heparin shorten term labor?EKMAN-ORDEBERG, Gunvor; AKERUD, Anna; DUBICKE, Aurelija et al.Acta obstetricia et gynecologica scandinavica. 2010, Vol 89, Num 1, pp 147-150, issn 0001-6349, 4 p.Article

A common standard is inappropriate for determining the potency of ultra low molecular weight heparins such as semuloparin and bemiparinJESKE, Walter P; HOPPENSTEADT, Debra; GRAY, Angel et al.Thrombosis research. 2011, Vol 128, Num 4, pp 361-367, issn 0049-3848, 7 p.Article

Long-Term Use of Low-Molecular-Weight Heparin in Hemodialysis Patients : A 7-Year ExperienceBERNIEH, B; BOOBES, Y; AL HAKIM, M. R et al.Blood purification. 2009, Vol 27, Num 3, pp 242-245, issn 0253-5068, 4 p.Article

The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancyMARIEKE KNOL, H; SCHULTINGE, Lejan; VEEGER, Nic J. G. M et al.Thrombosis research. 2012, Vol 130, Num 3, pp 334-338, issn 0049-3848, 5 p.Article

Dalteparin Dosing in High-Flux Haemodialysis and HaemodiafiltrationSRIDHARAN, Sivakumar; BERDEPRADO, Jocelyn; SIVALINGAM, Murugan et al.The Nephron journals. 2012, Vol 122, Num 1-2, pp 53-57, issn 1660-8151, 5 p.Article

The effects of heparin and low molecular weight heparins on boneRAJGOPAL, Raghav; BEAR, Mackenzie; BUTCHER, Martin K et al.Thrombosis research. 2008, Vol 122, Num 3, pp 293-298, issn 0049-3848, 6 p.Article

Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically III PatientsFOWLER, Robert A; MITTMANN, Nicole; ORMANIDHI, Orges et al.JAMA, the journal of the American Medical Association. 2014, Vol 312, Num 20, pp 2135-2145, issn 0098-7484, 11 p.Article

Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivoNORRBY, Klas; NORDENHEM, Arvid.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2010, Vol 118, Num 12, pp 949-957, issn 0903-4641, 9 p.Article

La thrombocytose au cours des traitements par héparine de bas poids moléculaire: une situation plus fréquente qu'on ne le croit? = Thrombocytosis in patients treated with low-molecular-weight heparin: More common than imagined?LAMBERT, M; TRILLOT, N; COOREN, G et al.Journal des maladies vasculaires. 2010, Vol 35, Num 6, pp 348-351, issn 0398-0499, 4 p.Article

Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparinMARCHETTI, Marina; VIGNOLI, Alfonso; RUSSO, Laura et al.Thrombosis research. 2008, Vol 121, Num 5, pp 637-645, issn 0049-3848, 9 p.Article

Dalteparin versus Unfractionated Heparin in Critically Ill PatientsThe New England journal of medicine. 2011, Vol 364, Num 14, pp 1305-1314, issn 0028-4793, 10 p.Article

Low-molecular-weight heparin pharmacokinetics: a dual absorption model approachABE, Sadahiro; CHIBA, Koji; SUWA, Toshio et al.International journal of clinical pharmacology and therapeutics. 2013, Vol 51, Num 6, pp 482-489, issn 0946-1965, 8 p.Article

Thromboelastographic evaluation of blood coagulation in the presence of branded and generic enoxaparinsWALENGA, J. M; JESKE, W. P; ESCALANTE, V et al.International angiology. 2012, Vol 31, Num 6, pp 517-525, issn 0392-9590, 9 p.Article

Low molecular weight (LMW) heparin inhibits injury-induced femoral artery remodeling in mouse via upregulating CD44 expressionGAOFENG ZHAO; SHAIK, Rahamthulla S; HANG ZHAO et al.Journal of vascular surgery. 2011, Vol 53, Num 5, pp 1359-1367, issn 0741-5214, 9 p.Article

Low-Molecular-Weight Heparin Overdose: Management by ObservationMONTE, Andrew A; BODMER, Michael; SCHAEFFER, Tammi H et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 11, pp 1836-1839, issn 1060-0280, 4 p.Article

Mechanism of low-molecular-weight heparin reversal by platelet factor 4FIORE, Martine M; MACKIE, Ian M.Thrombosis research. 2009, Vol 124, Num 1, pp 149-155, issn 0049-3848, 7 p.Article

Safety Assessment and Pharmacodynamics of a Novel Ultra Low Molecular Weight Heparin (RO-14) in Healthy Volunteers ― A First-Time-In-Human Single Ascending Dose StudyRICO, Salvador; MARIA ANTONIJOAN, Rosa; GICH, Ignasi et al.Thrombosis research. 2011, Vol 127, Num 4, pp 292-298, issn 0049-3848, 7 p.Article

Accuracy of a portable international normalized ratio monitor for patients receiving a low molecular weight heparin as a bridge pending full oral anticoagulant efficacyMEURIN, Ph; TABET, J. Y; MONCHI, M et al.Thrombosis research. 2010, Vol 125, Num 2, pp 192-195, issn 0049-3848, 4 p.Article

Malignancy and venous thrombosis in the critical care patientWU, Cynthia; LEE, Agnes Y.Critical care medicine. 2010, Vol 38, Num 2, issn 0090-3493, S64-S70, SUPArticle

Spontaneous Hemothorax Following Anticoagulation with Low-Molecular-Weight HeparinGANGULI, Amitava; WALKER, Lauren; JOAQUIM FITZGERALD, Richard et al.The Annals of pharmacotherapy. 2009, Vol 43, Num 9, pp 1528-1531, issn 1060-0280, 4 p.Article

Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparinMOAVENI, Daria K; LYNCH, Erin M; LUKE, Cathy et al.Journal of vascular surgery. 2008, Vol 47, Num 3, pp 616-624, issn 0741-5214, 9 p.Article

Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trialRODGER, Marc A; HAGUE, William M; REY, Evelyne et al.Lancet (British edition). 2014, Vol 384, Num 9955, pp 1673-1683, issn 0140-6736, 11 p.Article

Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: A pediatric experienceMORUF, A; SPYROPOULOS, A. C; SCHARDT, T. Q et al.Thrombosis research. 2012, Vol 130, Num 4, pp 612-615, issn 0049-3848, 4 p.Article

The roles of anticoagulants in patients with cancerLEE, Agnes Y. Y.Thrombosis research. 2010, Vol 125, issn 0049-3848, S8-S11, SUP2Conference Paper

  • Page / 4